GENMAB Trademark

Trademark Overview

On Thursday, December 14, 2006, a trademark application was filed for GENMAB with the United States Patent and Trademark Office. The USPTO has given the GENMAB trademark a serial number of 79040923. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Monday, November 19, 2018. This trademark is owned by Genmab A/S. The GENMAB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical scientific research, namely, biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS, acquired immune deficiency syndrome, and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis; patent exploitation, namely, patent licensing; licensing of intellectual property in the field of medicine; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies
genmab

General Information

Serial Number79040923
Word MarkGENMAB
Filing DateThursday, December 14, 2006
Status706 - SECTION 71 ACCEPTED
Status DateMonday, November 19, 2018
Registration Number3431559
Registration DateTuesday, May 20, 2008
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2008

Trademark Statements

Goods and ServicesMedical scientific research, namely, biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS, acquired immune deficiency syndrome, and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis; patent exploitation, namely, patent licensing; licensing of intellectual property in the field of medicine; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 21, 2007
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenmab A/S
Party Type30 - Original Registrant
Legal Entity Type84 - NOT AVAILABLE
AddressDK
Party NameGenmab A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK
Party NameGenmab A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events

Event DateEvent Description
Monday, August 27, 2007REFUSAL PROCESSED BY MPU
Thursday, August 16, 2007SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Monday, August 20, 2007LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Tuesday, August 21, 2007NEW APPLICATION ENTERED
Tuesday, August 21, 2007ASSIGNED TO EXAMINER
Saturday, August 25, 2007NON-FINAL ACTION WRITTEN
Sunday, August 26, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 4, 2008PUBLISHED FOR OPPOSITION
Monday, August 27, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 14, 2007REFUSAL PROCESSED BY IB
Wednesday, November 28, 2007PAPER RECEIVED
Thursday, January 10, 2008ASSIGNED TO LIE
Thursday, January 10, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 10, 2008AMENDMENT FROM APPLICANT ENTERED
Monday, January 28, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 30, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 13, 2008NOTICE OF PUBLICATION
Thursday, May 15, 2014REGISTERED-SEC.71 FILED
Tuesday, May 20, 2008REGISTERED-PRINCIPAL REGISTER
Thursday, August 21, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, September 10, 2008FINAL DISPOSITION PROCESSED
Wednesday, September 10, 2008FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 15, 2010CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, March 4, 2011INTERNATIONAL REGISTRATION RENEWED
Friday, November 11, 2011NEW REPRESENTATIVE AT IB RECEIVED
Saturday, December 29, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 15, 2014TEAS SECTION 71 RECEIVED
Tuesday, June 3, 2014REGISTERED-SEC.71 ACCEPTED
Wednesday, November 14, 2018TEAS SECTION 71 RECEIVED
Monday, June 2, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 4, 2014NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Thursday, February 9, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, February 9, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, April 20, 2017NEW REPRESENTATIVE AT IB RECEIVED
Saturday, May 20, 2017COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Friday, September 8, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, October 26, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, June 5, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 5, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Wednesday, June 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 15, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, November 19, 2018REGISTERED-SEC.71 ACCEPTED
Monday, November 19, 2018NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Thursday, February 25, 2021INTERNATIONAL REGISTRATION RENEWED

Related Keywords

genmab diseases medical monoclonal namely scientific research antibodies immune licensing programming